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Abstract
Background: Tissue Microarrays (TMAs) have emerged as a powerful tool for examining the distribution
of marker molecules in hundreds of different tissues displayed on a single slide. TMAs have been used
successfully to validate candidate molecules discovered in gene array experiments. Like gene expression
studies, TMA experiments are data intensive, requiring substantial information to interpret, replicate or
validate. Recently, an open access Tissue Microarray Data Exchange Specification has been released that
allows TMA data to be organized in a self-describing XML document annotated with well-defined common
data elements. While this specification provides sufficient information for the reproduction of the
experiment by outside research groups, its initial description did not contain instructions or examples of
actual implementations, and no implementation studies have been published. The purpose of this paper is
to demonstrate how the TMA Data Exchange Specification is implemented in a prostate cancer TMA.
Results: The Cooperative Prostate Cancer Tissue Resource (CPCTR) is funded by the National Cancer
Institute to provide researchers with samples of prostate cancer annotated with demographic and clinical
data. The CPCTR now offers prostate cancer TMAs and has implemented a TMA database conforming to
the new open access Tissue Microarray Data Exchange Specification. The bulk of the TMA database
consists of clinical and demographic data elements for 299 patient samples. These data elements were
extracted from an Excel database using a transformative Perl script. The Perl script and the TMA database
are open access documents distributed with this manuscript.
Conclusions: TMA databases conforming to the Tissue Microarray Data Exchange Specification can be
merged with other TMA files, expanded through the addition of data elements, or linked to data contained
in external biological databases. This article describes an open access implementation of the TMA Data
Exchange Specification and provides detailed guidance to researchers who wish to use the Specification.
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Background
TMA technology was introduced in 1998 [1]. A TMA fun-
damentally differs from a conventional glass slide only in
the number of tissue samples included [see Figure 1]. Tis-
sue microarrays typically contain between 100 and 1,000
core tissue samples. A single TMA block can be sectioned
and distributed to dozens of laboratories, saving years of
preparation time, hundreds of thousands of dollars in tis-
sue collection costs, and conserving experimental reagents
by measuring a marker's distribution on hundreds of
specimens arrayed on a single glass slide [1]. Several stud-
ies have demonstrated the value of TMAs to validate the
biologic relevance of candidate genes expressed in pros-
tate cancers [2-6].
Because TMAs are designed to answer questions applica-
ble to pathologic lesions with specific sets of attributes
(e.g. stage or grade or diagnostic subtype), preparation of
a TMA requires access to large archives of paraffin embed-
ded tissues. Each TMA core tissue must be annotated with
clinical, demographic or histopathologic information so
that measurements on the TMA core samples can result in
clinically useful correlations. To ensure inter-laboratory
reproducibility, information describing the preparation of
TMA blocks and slides need to be provided along with the
TMA data records.
The Cooperative Prostate Cancer Tissue Resource
(CPCTR) is a multi-institutional virtual tissue bank
funded by the U.S. National Cancer Institute (NCI) to
provide researchers with samples of prostate cancer tissues
[7]. The member institutions of the CPCTR are New York
University, George Washington University, University of
Pittsburgh and Medical College of Wisconsin. The CPCTR
began service to the cancer research community on
December 6, 2001. The CPCTR has over 5,000 prostate
cancer specimens including radical prostatectomy cases
(paraffin and fresh-frozen) and paraffinized needle biop-
sies. The CPCTR represents the largest repository of histo-
logically-characterized and clinically annotated prostate
cancer tissue in the USA. All accrued cases undergo pathol-
ogy review and all clinical data is collected using method-
ology standardized across the participating institutions.
CPCTR resources are available to all researchers, academic
and commercial. Further information can be obtained
from the CPCTR website [8].
The CPCTR has constructed a prostate cancer TMA imple-
mented in conformance with the new TMA Data Exchange
Specification (herinafter designated "the Specification").
The Specification was developed through a series of open
workshops sponsored by the National Cancer Institute
and the Association for Pathology Informatics [9]. Tissue
data included in the CPCTR TMA database is de-identi-
fied, and assembled in an open access database to permit
data sharing, in compliance with current NIH policy on
data sharing [10] and in concert with ongoing NIH initia-
tives to develop new methods for sharing research data
[11,12].
Results and Discussion
The TMA data exchange specification was designed to
allow TMA database files to be totally self-describing. The
properties of a self-describing database file would include:
1. An informative header that explained the purpose of
the file and provided all the information to understand
the file (i.e., its organization).
2. Information regarding the creation of the file (e.g., cre-
ator, date of creation)
3. Rights of use (e.g. specifying any restrictions on use)
4. Warranty information
5. Methodology (e.g. how the data contained in the file
was obtained)
6. Data
7. Metadata (the data that describes or defines the actual
data)
8. Metadata definitions (clear descriptions and definitions
of the metadata)
The typical database contains data (property #6) but
nothing else in the way of self-descriptive annotation. The
Prostate Cancer TMA slide Figure 1
Prostate Cancer TMA slide. Hematoxylin & Eosin stained 
example of a TMA slide of prostate samples.BMC Bioinformatics 2004, 5 http://www.biomedcentral.com/1471-2105/5/19
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CPCTR implementation of the Specification has all eight
properties and employs the following enhancements:
1. Uses Uniform Resource Locators (URLs) to link the
TMA database with web documents that provide detailed
information supplementing the metadata tags. These
external URLs are:
a. A link to the Dublin Core Meta Data Elements used in
the header section of the document [13].
b. A link to the ISO-11179-compliant listing of Common
Data Elements (CDEs) provided in the Specification [14].
c. A link to the CPCTR CDEs [15].
d. Links to external documents that provide methodolo-
gies for preparing CPCTR TMA blocks and sectioning
slides [16,17].
3. Supports complex TMAs within a single TMA file. In
this case, a single TMA file contained four blocks, with
cores from a single tissue samples appearing in multiple
locations in more than one block.
2. Protects patient privacy (by deidentifying all data)
3. Allows data sharing (by permitting free distribution of
the XML data document)
Conclusions
Tissue microarrays allow for the high throughput analysis
of tissue samples and their association with clinical or
outcomes data. Yet these experiments require a large
amount of information for the subsequent analysis and
evaluation, in particular by interested second parties. The
Specification provides an accurate and reproducible
method for the transfer of this information as is required
for inter-laboratory reproducibility. One of the most
important problems with modern data specifications is
the daunting technical expertise required for their imple-
mentation. The Specification was written to permit
maximal flexibility and minimal implementation require-
ments [9]. This study demonstrates that the Specification
can be implemented using a simple Perl script that con-
verts an Excel database into XML-tagged data elements.
The resulting large section of core-related XML text can be
simply inserted into a conformant document containing
header, block and slide information. The resulting TMA
database can be validated with a Perl script provided with
the Specification document.
Methods
Human subjects protections
All institutions participating in the CPCTR have Institu-
tional Review Board (IRB) approval for human subjects
research. Each CPCTR institution develops its own local
protocols to protect the confidentiality and privacy of
human subjects and obtains local IRB approval for all
CPCTR activities. The IRB assurance numbers for each
cooperating institution are: New York University –
M1177; Medical College of Wisconsin – M1061; Univer-
sity of Pittsburgh Medical Center – M1256; and George
Washington University Medical Center – M1125. Tissue
data records from the cooperating institutions are submit-
ted to a central data manager (Information Management
Services, Inc., contracted by the NCI) as de-identified
records. All institutions assign an arbitrary number to
each record before submitting the de-identified record to
the central database. This ensures that the central database
has no links connecting records to patients. In addition,
HIPAA's proscribed set of 18 data elements are omitted
from core sample records (so-called safe harbor approach
to HIPAA-compliance) [18].
Tissue and data collection
The CPCTR maintains a publicly available Manual of
Operations that describes its tissue collection procedures
and policies [19].
Simplest conforming TMA file Figure 2
Simplest conforming TMA file. Image displaying the sim-
plest possible XML file conforming to the TMA Data 
Exchange Specification.BMC Bioinformatics 2004, 5 http://www.biomedcentral.com/1471-2105/5/19
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Pathological characterization of specimens involves
review of all cases by a CPCTR pathologist using diagnos-
tic criteria explained in the publicly available CPCTR his-
tologic atlas and manual [20].
Protocols for the construction the TMA block and TMA
slide are publicly available documents available at the
CPCTR web site and linked from the TMA Database
[16,17].
The TMA Data Exchange Specification
The Specification is an open access document that can be
used without restriction [9].
The Specification requires four general sections for each
TMA file:
1) Header, containing the specification Dublin Core iden-
tifiers, 2) Block, describing the paraffin-embedded array
of tissues, 3) Slide, describing the glass slides produced
from the Block, and 4) Core, containing all data related to
the individual tissue samples contained in the array. The
simplest possible structure for a conforming TMA file con-
sists of nothing more than empty tags designating the four
required sections [see Figure 2] [9].
Common Data Elements (CDEs) are metadata tags that
describe the data elements included in an XML database.
To be of value, CDEs must be well-defined, uniquely iden-
tified and available for human review or computer access.
Eighty CDEs, conforming to the ISO-11179 [21] specifica-
tion for data elements constitute the XML tags provided in
the Specification [9]. CDE descriptors are publicly availa-
ble [14]. However, the only CDEs that must appear in any
conforming TMA file are the section CDEs (header, block,
slide and core), the root CDE (histo) and the tma CDE
itself (tma). A set of six simple semantic rules describe the
syntax for the data exchange specification [9].
The Specification was designed for maximal flexibility.
Flexibility in the first version of an XML specification per-
mits the addition of greater structure in later versions built
on tested implementations. A similar approach has been
used for ANSI/HL7 Common Data Architecture (CDE)
wherein the earliest version (Level One) is intentionally
sparse [22]. At this time, there is no DTD (Data Type Def-
inition) or Schema included in the Specification. For
those wishing to use a DTD, a Specification-compliant
DTD has been prepared by David G. Nohle, Ohio State
University Department of Pathology and the Mid-Region
AIDS & Cancer Specimen Resource (ACSR) [23].
Constructing the TMA Data file
Constructing a TMA Database consists of the following:
1. Filling the four sections (header, block, slide and core)
2. Assembling the four sections into a TMA file with a
proper file declaration, root element and TMA CDE.
3. Validating that the TMA file conforms to the
specification
The header, block and slide sections of the TMA will vary
only slightly from project to project within a laboratory.
The CPCTR header, block and slide sections were pre-
pared "by hand" using the section-specific CDEs provided
in the specification.
The header section contains descriptive information
about the file and its contents. With the exception of one
CDE (filename), the header CDEs are the same CDEs used
in the Dublin Core set of XML identifiers used by librari-
ans. Detailed information describing the Dublin Core ele-
ments is available [13]. A link to the Dublin Core
elements is also included in CPCTR TMA database. The
TMA XML opening section Figure 3
TMA XML opening section. Image displaying the first few 
lines of the TMA XML document.
Core Array Mapping Image Figure 4
Core Array Mapping Image. Schematic image showing 
the array locations of cores listed in the TMA doucment.BMC Bioinformatics 2004, 5 http://www.biomedcentral.com/1471-2105/5/19
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first few lines of the TMA database are shown [see Figure
3]. The block and slide headers of the TMA database are
short and are also completed manually.
The cores are distributed for each block in an array, with
cores assigned to specific locations [see Figure 4], and all
the cores in an array are assigned to a slide, which is a
numbered section derived from a block [see Figure 5]. The
core section contains annotated data for each core in the
TMA. The central database for all CPCTR tissues is main-
tained as an Excel database by an NCI-contracted infor-
mation management service (IMS, Rockville, MD). IMS
extracts an Excel sub-file consisting of records pertaining
to the tissues selected for the TMA block. CPCTR-specific
data elements included in the IMS records are publicly
available [15].
A Perl script was written that converts Excel files to XML,
enclosing the data associated with the spreadsheet cells to
XML CDEs corresponding to the column headings. This
creates the "core" section of the TMA database. A sample
of an XML-tagged extracted data record is shown [see Fig-
ure 6]. The Perl script is available as an open access file
with this article [see Additional file 1].
The CPCTR prostate cancer TMA consists of 299 core sam-
ples distributed in four blocks, each block having 300
arrayed cores. Each block contains about 150 core
samples in two different locations in each block. The core
duplicates are staggered in the array, to maximize the
chance that a given core will be represented if an area of
the slide section is lost in processing. The distribution of
one set of core samples in multiple array locations in four
blocks yields a complex TMA that cannot be adequately
represented by separate descriptions of each block. The
Specification permits multi-block TMA files. Within the
block CDE are the nested sets of four blocks that compose
the complex TMA. Each core CDE is nested within a
specific block CDE, and one core may have two associated
array locations [see Figure 6].
The four sections are concatenated as a single XML data-
base file. The CPCTR database file is provided with this
manuscript [see Additional file 2].
Validating the TMA Data file
Once a TMA database is prepared, it needs to be validated
to ensure conformance with the Specification. At this
time, all TMA files should be validated using a software
implementation written in Perl and distributed as an
open access supplemental file with the Specification and
with this publication [see Additional file 3]. The
validating script requires a Perl installation but should
operate equally well on any operating system. The valida-
tion software has a simple command-line interface. When
the file successfully validates, the Perl script outputs the
encountered CDEs from the Specification, a statement
that the file is valid, and a one-way hash value specific for
the validated file [see Figure 7].
Availability and requirements
The Perl scripts and files for the production of TMA data-
bases that meet the Specification are available with this
publication. The example prostate cancer TMA database is
available as a supplementary file with this article [see
Additional file 1]. The actual tissue microarray slides are
available after an application process Although the
CPCTR is a non-profit, government-sponsored resource, a
surcharge is attached for glass slides, to help defray a por-
tion of the costs of TMA production. The application proc-
ess and charges are described at the CPCTR web site [8].
Questions regarding any aspect of the CPCTR can be
directed to the CPCTR email query service [ask-cpctr-
l@list.nih.gov].
TMA XML slide section information Figure 5
TMA XML slide section information. Image displaying 
the data elements describing the glass slide sectioning 
information.
TMA XML core section information Figure 6
TMA XML core section information. Image displaying 
the data elements comprising a record for a single tissue 
core.BMC Bioinformatics 2004, 5 http://www.biomedcentral.com/1471-2105/5/19
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